Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention.

PubWeight™: 3.23‹?› | Rank: Top 1%

🔗 View Article (PMID 19171857)

Published in Circulation on January 26, 2009

Authors

William S Harris, Dariush Mozaffarian, Eric Rimm, Penny Kris-Etherton, Lawrence L Rudel, Lawrence J Appel, Marguerite M Engler, Mary B Engler, Frank Sacks

Associated clinical trials:

Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans (OXGEN-2014) | NCT02317588

Articles citing this

(truncated to the top 100)

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ (2013) 3.78

Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation (2014) 2.95

Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation (2014) 2.63

Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr (2010) 2.23

Health implications of high dietary omega-6 polyunsaturated Fatty acids. J Nutr Metab (2012) 1.68

The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47

Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr (2011) 1.44

Understanding nutritional epidemiology and its role in policy. Adv Nutr (2015) 1.37

New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med (2012) 1.28

Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med (2012) 1.27

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation (2015) 1.25

Readily available sources of long-chain omega-3 oils: is farmed Australian seafood a better source of the good oil than wild-caught seafood? Nutrients (2014) 1.24

Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort. Am J Clin Nutr (2011) 1.24

Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med (2013) 1.22

ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy. Genes Dev (2013) 1.22

Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care (2011) 1.22

Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res (2012) 1.22

Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr (2011) 1.20

Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr (2009) 1.19

Energy intake and leukocyte telomere length in young adults. Am J Clin Nutr (2012) 1.18

The omega-3 fatty acid nutritional landscape: health benefits and sources. J Nutr (2012) 1.14

Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation (2016) 1.13

Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J Lipid Res (2012) 1.12

Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res (2010) 1.10

ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med (2016) 1.05

High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res (2011) 1.05

Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract (2010) 1.04

Ethnicity, plasma phospholipid fatty acid composition and inflammatory/endothelial activation biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Clin Nutr (2012) 1.02

Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr (2012) 1.02

Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res (2012) 1.00

Consequences of essential fatty acids. Nutrients (2012) 0.99

Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. PLoS One (2012) 0.98

Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc Res (2012) 0.97

Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes. Int J Cancer (2011) 0.97

Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Am J Clin Nutr (2009) 0.95

Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue. JPEN J Parenter Enteral Nutr (2013) 0.95

Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. Lipids (2013) 0.92

Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence. Biomed Res Int (2015) 0.90

Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res (2012) 0.90

All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. World Rev Nutr Diet (2011) 0.90

Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients (2014) 0.89

Variants in CPT1A, FADS1, and FADS2 are Associated with Higher Levels of Estimated Plasma and Erythrocyte Delta-5 Desaturases in Alaskan Eskimos. Front Genet (2012) 0.89

The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles. Obesity (Silver Spring) (2013) 0.88

Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice. Br J Nutr (2012) 0.88

Erythrocyte very long-chain saturated fatty acids associated with lower risk of incident sudden cardiac arrest. Prostaglandins Leukot Essent Fatty Acids (2014) 0.88

Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am J Physiol Heart Circ Physiol (2014) 0.88

Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study. Am J Clin Nutr (2010) 0.87

Serum levels of marine-derived n-3 fatty acids in Icelanders, Japanese, Koreans, and Americans--a descriptive epidemiologic study. Prostaglandins Leukot Essent Fatty Acids (2012) 0.87

Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study. Clin Nutr (2011) 0.86

DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am J Clin Nutr (2014) 0.86

Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives. Adv Nutr (2015) 0.85

Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer (2010) 0.85

Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients (2016) 0.85

Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) (2011) 0.84

Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. Eur J Appl Physiol (2014) 0.84

Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol (2010) 0.83

Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J Lipid Res (2010) 0.83

Quality and adequacy of dietary intake in a southern urban heart failure population. J Cardiovasc Nurs (2013) 0.82

DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov (2012) 0.81

Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up. Lipids Health Dis (2014) 0.81

Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal. Cardiovasc Res (2011) 0.81

Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter. Curr Opin Pediatr (2010) 0.81

Impact of the dietary fatty acid intake on C-reactive protein levels in US adults. Medicine (Baltimore) (2017) 0.81

Genetic Variants in the FADS Gene: Implications for Dietary Recommendations for Fatty Acid Intake. Curr Nutr Rep (2014) 0.81

A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women. Eur J Nutr (2015) 0.81

Leukotriene A4 hydrolase haplotype, diet and atherosclerosis: a twin study. Atherosclerosis (2012) 0.80

Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study. Am J Clin Nutr (2012) 0.80

N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis. PLoS One (2013) 0.80

Higher Plasma Phospholipid n-3 PUFAs, but Lower n-6 PUFAs, Are Associated with Lower Pulse Wave Velocity among Older Adults. J Nutr (2015) 0.80

Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt. Am J Trop Med Hyg (2014) 0.80

Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver. J Lipid Res (2015) 0.80

Ruminant-produced trans-fatty acids raise plasma total and small HDL particle concentrations in male Hartley guinea pigs. J Nutr (2010) 0.80

The science of fatty acids and inflammation. Adv Nutr (2015) 0.79

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. J Psychosom Res (2013) 0.79

Don't disregard the essential distinction between PUFA species. Br J Nutr (2011) 0.79

Maternal and pregnancy related predictors of cardiometabolic traits in newborns. PLoS One (2013) 0.79

Dietary intake of fats and fatty acids in the Korean population: Korea National Health and Nutrition Examination Survey, 2013. Nutr Res Pract (2015) 0.78

Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells. Lipids Health Dis (2014) 0.78

Major urinary metabolites of 6-keto-prostaglandin F2α in mice. J Lipid Res (2013) 0.78

Significant inverse associations of serum n-6 fatty acids with plasma plasminogen activator inhibitor-1. Br J Nutr (2011) 0.78

A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1α expression and mitochondrial biogenesis. PLoS One (2012) 0.78

Importance of fatty acid compositions in patients with peripheral arterial disease. PLoS One (2014) 0.77

Structural equation modeling for analyzing erythrocyte fatty acids in Framingham. Comput Math Methods Med (2014) 0.77

Association between serum fatty acids and lipoprotein subclass profile in healthy young adults: exploring common genetic and environmental factors. Atherosclerosis (2014) 0.77

Lower Protein-to-Carbohydrate Ratio in Maternal Diet is Associated with Higher Childhood Systolic Blood Pressure up to Age Four Years. Nutrients (2015) 0.77

Impact of omega-6 fatty acids on cardiovascular outcomes: A review. J Preventive Cardiol (2013) 0.77

Linoleic acid. Adv Nutr (2013) 0.76

Leukotriene haplotype × diet interaction on carotid artery hypertrophy and atherosclerosis in American Indians: the Strong Heart Family Study. Atherosclerosis (2014) 0.76

Nutraceutical therapies for atherosclerosis. Nat Rev Cardiol (2016) 0.76

Dietary intake of nuts and cardiovascular prognosis. Ochsner J (2009) 0.76

Fat chance for longevity. Genes Dev (2013) 0.76

Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice. Atherosclerosis (2014) 0.76

Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans. Br J Nutr (2015) 0.76

Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase. Biochemistry (2016) 0.76

Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats. Int J Physiol Pathophysiol Pharmacol (2014) 0.75

Omega-6 polyunsaturated fatty acids: is a broad cholesterol-lowering health claim appropriate? CMAJ (2013) 0.75

Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies. J Child Adolesc Psychopharmacol (2017) 0.75

Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance. Prostaglandins Leukot Essent Fatty Acids (2013) 0.75

Articles by these authors

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (2004) 11.95

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA (2008) 8.45

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation (2005) 8.11

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA (2002) 7.93

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ (2007) 7.54

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88

Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation (2009) 5.82

Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation (2010) 5.58

A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29

Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med (2013) 5.28

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00

Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74

Measuring blood pressure accurately: new and persistent challenges. JAMA (2003) 4.73

Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med (2006) 4.66

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16

Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med (2008) 3.79

Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation (2008) 3.76

Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.63

Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ (2014) 3.56

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 3.42

Lower levels of sodium intake and reduced cardiovascular risk. Circulation (2014) 3.39

Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14

State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation (2009) 3.05

Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest (2007) 3.01

Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95

The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension (2003) 2.87

Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) (2005) 2.86

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ (2006) 2.85

n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr (2003) 2.82

Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med (2009) 2.81

Components of a cardioprotective diet: new insights. Circulation (2011) 2.81

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72

High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr (2013) 2.66

Omega-3 fatty acids for cardioprotection. Mayo Clin Proc (2008) 2.65

Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc (2010) 2.60

Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54

Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis (2012) 2.51

A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 2.49

IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med (2012) 2.47

Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46

Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation (2003) 2.45

Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int (2005) 2.43

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open (2013) 2.40

Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation (2009) 2.34

Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ (2011) 2.34

Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet (2011) 2.33

Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr (2003) 2.29

Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults. Circulation (2010) 2.29

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol (2011) 2.20

Do healthier foods and diet patterns cost more than less healthy options? A systematic review and meta-analysis. BMJ Open (2013) 2.15